Salivary Biomarkers

How it works

Benefits

Highlighted claims

• Salivary cortisol is an end product of the HPA axis and a physiological stress-response indicator measurable accurately in saliva. — Effect of enhanced support for coping with side effects during medication counselling on the nocebo effect in patients with advanced lung cancer receiving initial chemotherapy: protocol for a multicentre exploratory open-label randomised controlled trial
• Cortisol has a marked diurnal rhythm with high levels in the early morning and low levels at night, requiring standardized sample collection times. — Effect of enhanced support for coping with side effects during medication counselling on the nocebo effect in patients with advanced lung cancer receiving initial chemotherapy: protocol for a multicentre exploratory open-label randomised controlled trial
• The Cube Reader system for saliva analysis does not require specialized analytical infrastructure such as ELISA. — Effect of enhanced support for coping with side effects during medication counselling on the nocebo effect in patients with advanced lung cancer receiving initial chemotherapy: protocol for a multicentre exploratory open-label randomised controlled trial
• Using salivary cortisol and IgA objectively assesses physiological stress responses, reducing reliance on self-report alone. — Effect of enhanced support for coping with side effects during medication counselling on the nocebo effect in patients with advanced lung cancer receiving initial chemotherapy: protocol for a multicentre exploratory open-label randomised controlled trial
• Salivary IgA is the predominant immunoglobulin in mucus secretions from salivary glands and may be regulated by acute and chronic stress. — Effect of enhanced support for coping with side effects during medication counselling on the nocebo effect in patients with advanced lung cancer receiving initial chemotherapy: protocol for a multicentre exploratory open-label randomised controlled trial